THOR proposes the development of a revolutionary tissue engineering technology, capable to produce any patient- tailored tissues for organ repair or replacement.
Funded by the European Union’s EIC-Pathfinder Programme, under the Grant Agreement number 101099719
(1) the establishment of a Tissue Engineering industry for personalized organ repair, producing any type of well vascularized and fully functioning tissues and
(2) the maintenance of such tissues alive for long periods of time, for an easy transportation to hospitals and clinics, even far from the big cities. THOR will foster the rise of a new industry and of a new biomedical field, while cadaveric donors' transplants will not be necessary.
